Literature DB >> 10215503

Terbinafine and fulminant hepatic failure.

K Agarwal, D M Manas, M Hudson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10215503     DOI： 10.1056/NEJM199904223401617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Drug-Induced Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Current Management of Onychomycosis and Dermatomycoses.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

Review 3.  Systematic review of severe acute liver injury caused by terbinafine.

Authors:  Jun Yan; Xiaolin Wang; Shengli Chen
Journal:  Int J Clin Pharm       Date:  2014-07-02

Review 4.  Fungal toenail infections.

Authors:  Jill Ferrari
Journal:  BMJ Clin Evid       Date:  2011-08-16

Review 5.  Fungal toenail infections.

Authors:  Jill Ferrari
Journal:  BMJ Clin Evid       Date:  2008-12-15

6.  Risk of oral antifungal agent-induced liver injury in Taiwanese.

Authors:  Wei-Yu Kao; Chien-Wei Su; Yi-Shin Huang; Yueh-Ching Chou; Yi-Chih Chen; Wen-Hung Chung; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 7.  Fungal toenail infections.

Authors:  Jill Ferrari
Journal:  BMJ Clin Evid       Date:  2014-03-13

8.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

Review 9.  Drug-induced cholestasis.

Authors:  Vinay Sundaram; Einar S Björnsson
Journal:  Hepatol Commun       Date:  2017-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.